1. BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model

Volume 21, Issue 1, January 2020, Pages 1-1

Ebubekir Dirican

• View Article
• PDF 214.78 K

2. PIK3CA and PTEN Genes Expressions in Breast Cancer

Volume 20, Issue 9, September 2019, Pages 2841-2846

Nabil Hadi Alowiri; Shaden Muawia Hanafy; Reham Abdel Haleem; Ahmed Abdellatif

• View Article
• PDF 318.24 K

3. Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population

Volume 20, Issue 7, July 2019, Pages 2103-2107

Ourlad Alzeus G Tantengco; Yukiko Nakura; Michinobu Yoshimura; Erlidia F Llamas-Clark; Itaru Yanagihara

• View Article
• PDF 306.69 K

4. BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model

Volume 18, Issue 8, August 2017, Pages 2209-2213

Satyajit Patra; Vanesa Young; Leslie Llewellyn; Jitendra Senapati; Jesil Mathew

• View Article
• PDF 312.71 K

5. PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian Patients

Volume 18, Issue 1, January 2017, Pages 57-64

Fatma Elwy; Reham Helwa; Asmaa A. El Leithy; Zeinab Shehab El-din; Magda M. Assem; Nagwa H. A. Hassan

• View Article
• PDF 512.12 K

6. Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Volume 17, Issue 2, February 2016, Pages 539-543

• View Article
• PDF 560.1 K

7. Detection of PIK3CA Gene Mutations with HRM Analysis and Association with IGFBP-5 Expression Levels in Breast Cancer

Volume 15, Issue 21, December 2014, Pages 9327-9333

• View Article
• PDF 1.26 MB

8. PIK3CA and AKT Gene Polymorphisms in Susceptibility to Osteosarcoma in a Chinese Population

Volume 14, Issue 9, September 2013, Pages 5117-5122

• View Article
• PDF 979.69 K

9. Mutational Analysis of Key EGFR Pathway Genes in Chinese Breast Cancer Patients

Volume 13, Issue 11, November 2012, Pages 5599-5603

• View Article
• PDF 442.59 K